CDK6 and acute promyelocytic leukemia: To explore the clinical feature of CDK6 expression in non-APL AML patients, we compared the clinical characteristics of non-APL AML patients between CDK6high and CDK6low groups (divided by the median level of CDK6 expression) (Table 2).